The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma.
Morton
D L
DL
Sonya Valley Ghidossi Vaccine Laboratory, the Roy E. Coats Research Laboratories, and the Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA. mortond@jwci.org
Cochran
A J
AJ
D006801:Humans; D007108:Immune Tolerance / Q000502:physiology; D008017:Life Expectancy; D008197:Lymph Node Excision / Q000379:methods; D008207:Lymphatic Metastasis / Q000276:immunology / Q000473:pathology*; D008545:Melanoma / Q000276:immunology / Q000556:secondary* / Q000601:surgery; D009367:Neoplasm Staging; D011379:Prognosis; D021701:Sentinel Lymph Node Biopsy / Q000706:statistics & numerical data*; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology* / Q000601:surgery; D013997:Time Factors